Skip to main content

pathology microbiology and immunology

Study explores anti-viral potential of existing drugs

Sep. 15, 2016—Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market.

Read more


Restore T cells to fight leukemia

Sep. 14, 2016—Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.

Read more


Team explores transcription factor’s autoimmunity role

Aug. 11, 2016—Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently.

Read more


Study explores low oxygen’s impact on antibody quality

Aug. 11, 2016—Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order.

Read more


These days, fecal transplantation is no joke

Jul. 12, 2016—Fecal transplants are increasingly being used to treat certain human illnesses and more scientists have begun to research the transplants' effects in animals.

Read more


‘Young Scientist’ showcases high schoolers’ research at Vanderbilt

Jun. 2, 2016—High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.

Read more


VUMC researchers seek to crack the code of neonatal sepsis

Jun. 2, 2016—Sepsis, an exaggerated and overwhelming inflammatory response to infection, is a major worldwide killer of babies in the first four weeks of life (neonatal period).

Read more


Wound healing society honors VUMC’s Davidson

May. 26, 2016—Jeff Davidson, Ph.D., professor of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, was honored last month at the joint 27th annual Symposium on Advanced Wound Care and Wound Healing Society meeting in Atlanta for “outstanding lifetime achievement in wound healing.”

Read more


Improving natural killer cancer therapy

Apr. 29, 2016—A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies.

Read more


An Argonaute’s voyage to cancer

Apr. 28, 2016—A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”

Read more


Immune defenses in asthma

Apr. 5, 2016—Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

Read more


Zutter takes part in cancer strategy meet at White House

Feb. 4, 2016—Vanderbilt physician/scientist Mary Zutter, M.D., Louise B. McGavock Professor of Pathology, Microbiology and Immunology and assistant vice chancellor for Integrative Diagnostics, can now add “White House guest” to her resume.

Read more


VIEW MORE EVENTS >